RIA
LLY icon

Rhodes Investment Advisors’s Eli Lilly LLY Stock Holding History

Rhodes Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606K Hold
505
– – 0.45% 60
2026
Q1 		$464K Sell
505
-60
-11% -$60.8K 0.4% 69
2025
Q4 		$607K Buy
+565
New +$540K 0.49% 63

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rhodes Investment Advisors's LLY Position: Q2 2026 in Review

Rhodes Investment Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 505 shares worth $606K. The position accounts for 0.45% of the portfolio, ranked #60.

Rhodes Investment Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $607K in Q4 2025. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rhodes Investment Advisors held 505 shares of Eli Lilly worth $606K as of Q2 2026.
  • Rhodes Investment Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.45% of Rhodes Investment Advisors's portfolio in Q2 2026, its #60 holding.
  • Rhodes Investment Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Rhodes Investment Advisors's Eli Lilly position peaked at $607K in Q4 2025.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rhodes Investment Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.